News 24 Mag 2024 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
News 10 Mag 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 Ott 2024–24 Ott 2024 Malham Arabia Saudita
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 Ott 2024–24 Ott 2024 Malham Arabia Saudita
News 04 Apr 2024 Terra Quantum seeking to drive quantum computing innovations in Asia Terra Quantum has its sights set on contributing to the development of quantum-enhanced innovations in Asia. To this end, the St.Gallen-based fir...
News 24 Gen 2024 Odne secures fifth investment from the Dental Innovation Alliance The North American venture capital firm Dental Innovation Alliance has made a fifth investment in Odne. This will support the market launch of an...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 Ott 2024–24 Ott 2024 Malham Arabia Saudita
News 27 Ott 2023 Roche uses artificial intelligence for cancer diagnosis Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence (AI). The goal is to help patholo...
News 21 Nov 2023 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 Ott 2024–24 Ott 2024 Malham Arabia Saudita
News 23 Nov 2023 biped.ai secures CHF 1.2 million for US expansion and European growth Lausanne-based start-up biped.ai, known for its revolutionary technology aiding the visually impaired, has successfully raised CHF 1.2 million.
News 18 Ott 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
Aktuell 21 Nov 2023 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...